Single Ascending Oral Doses of SY-008 in Healthy Subjects
NCT03462589
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Interventions
DRUG:
SY-008
Sponsor
Suzhou Yabao Pharmaceutical R&D Co., Ltd.